MiMedx Group (MDXG) Receives a Buy from Craig-Hallum
In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on MiMedx Group. The company’s shares opened today at $7.68.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Knickerbocker is a 5-star analyst with an average return of 27.3% and a 60.76% success rate. Knickerbocker covers the Healthcare sector, focusing on stocks such as Harrow Health, Delcath Systems, and Celcuity.
Currently, the analyst consensus on MiMedx Group is a Strong Buy with an average price target of $12.00, a 56.25% upside from current levels. In a report released today, Lake Street also reiterated a Buy rating on the stock with a $12.00 price target.
MDXG market cap is currently $1.06B and has a P/E ratio of 33.33.
Read More on MDXG:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.